Optimal management of venous thromboembolism in adolescent and young adult oncology patients

被引：3
作者：
McKillop, Sarah [1 ]
Wu, Cynthia [2 ]
Bruce, Aisha [1 ]
Brandwein, Joseph [2 ]
机构：
[1] Univ Alberta, Div Immunol Hematol Oncol Palliat Care & Environm, Dept Pediat, Edmonton, AB, Canada
[2] Univ Alberta, Div Hematol, Dept Med, 11350,83 Ave, Edmonton, AB T6G 2G3, Canada
来源：
CLINICAL ONCOLOGY IN ADOLESCENTS AND YOUNG ADULTS | 2016年 / 6卷
关键词：
adolescents; young adults; thrombosis; cancer; venous thromboembolism; anticoagulation;
D O I：
10.2147/COAYA.S51146
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Venous thromboembolism (VTE) is a serious complication experienced by adolescents and young adults (AYAs) diagnosed with cancer. Data exist in the adult literature to guide the management of cancer-associated thrombosis. Unfortunately, little is known regarding the epidemiology of cancer-associated thrombosis in AYAs. As a result, evidence on the treatment and prevention of thrombosis in this vulnerable population is lacking, posing a great challenge to physicians caring for AYAs with cancer. It is clear that the basic principles of VTE likely apply to AYAs and that low-molecular-weight heparin is the drug of choice for the treatment of VTE regardless of age. We review the available data on the epidemiology, diagnostic methods, and management of AYAs with cancer and VTE. Recognizing the lack of accepted guidelines for the prevention or management of VTE in this population, we offer expert opinion recommendations to serve as guidance to improve management of thrombosis in AYA cancer patients.
引用
收藏
页码：39 / 49
页数：11
相关论文
共 82 条
  • [31] Duration of anticoagulant therapy for deep vein thrombosis and pulmonary embolism
    Kearon, Clive
    Akl, Elie A.
    [J]. BLOOD, 2014, 123 (12) : 1794 - 1801
  • [32] Antithrombotic Therapy for VTE Disease Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence- Based Clinical Practice Guidelines
    Kearon, Clive
    Akl, Elie A.
    Comerota, Anthony J.
    Prandoni, Paolo
    Bounameaux, Henri
    Goldhaber, Samuel Z.
    Nelson, Michael E.
    Wells, Philip S.
    Gould, Michael K.
    Dentali, Francesco
    Crowther, Mark
    Kahn, Susan R.
    [J]. CHEST, 2012, 141 (02) : E419S - +
  • [33] Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy
    Khorana, A. A.
    Francis, C. W.
    Culakova, E.
    Kuderer, N. M.
    Lyman, G. H.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 (03) : 632 - 634
  • [34] Khorana A A, 2012, J Thromb Haemost, V10, P2602
  • [35] Development and validation of a predictive model for chemotherapy-associated thrombosis
    Khorana, Alok A.
    Kuderer, Nicole M.
    Culakova, Eva
    Lyman, Gary H.
    Francis, Charles W.
    [J]. BLOOD, 2008, 111 (10) : 4902 - 4907
  • [36] A pilot study of central venous catheter survival in cancer patients using low-molecular-weight heparin (dalteparin) and warfarin without catheter removal for the treatment of upper extremity deep vein thrombosis (The Catheter Study)
    Kovacs, M. J.
    Kahn, S. R.
    Rodger, M.
    Anderson, D. R.
    Andreou, R.
    Mangel, J. E.
    Morrow, B.
    Clement, A. M.
    Wells, P. S.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 (08) : 1650 - 1653
  • [37] Impact of Venous Thromboembolism and Anticoagulation on Cancer and Cancer Survival
    Kuderer, Nicole M.
    Ortel, Thomas L.
    Francis, Charles W.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (29) : 4902 - 4911
  • [38] Epidemiology and prevention of catheter-related thrombosis in patients with cancer
    Lee, A. Y. Y.
    Kamphuisen, P. W.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2012, 10 (08) : 1491 - 1499
  • [39] Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer A Randomized Clinical Trial
    Lee, Agnes Y. Y.
    Kamphuisen, Pieter W.
    Meyer, Guy
    Bauersachs, Rupert
    Janas, Mette S.
    Jarner, Mikala F.
    Khorana, Alok A.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 314 (07): : 677 - 686
  • [40] Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer
    Lee, AYY
    Levine, MN
    Baker, RI
    Bowden, C
    Kakkar, AK
    Prins, M
    Rickles, FR
    Julian, JA
    Haley, S
    Kovacs, MJ
    Gent, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (02) : 146 - 153
123456789